TrumpRx Platform Launch Delayed Amid Senatorial Scrutiny
The Trump administration has delayed the release of TrumpRx, an online platform for purchasing discounted prescription drugs directly from pharmaceutical companies, as Democratic senators question the platform’s legality and oversight. Lawmakers have raised concerns regarding potential conflicts of interest and regulatory compliance. The delay coincides with scrutiny over how the government will monitor such direct-to-consumer pharmaceutical platforms.